%0 Journal Article %T Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study %A A. Jorsal %A C. D. A. Stehouwer %A C. G. Schalkwijk %A H.-H. Parving %A J. Buijs %A L. Engelen %A L. Tarnow %A P. Rossing %A S. A. Peeters %J Archive of "Cardiovascular Diabetology". %D 2017 %R 10.1186/s12933-017-0539-1 %X Altered regulation of extracellular matrix remodeling by matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) may contribute to vascular complications in type 1 diabetes. We investigated associations between plasma MMP-1, -2, -3, -9, -10 and TIMP-1, and cardiovascular events and all-cause mortality in type 1 diabetic patients %K Type 1 diabetes %K Cardiovascular disease %K All-cause mortality %K Matrix metalloproteinase %K Tissue inhibitor of metalloproteinase %K Estimated glomerular filtration rate %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405549/